Physician profile
Michael Roth
NPI 1104911486
$1,273.28
in general payments reported to CMS, 2019-2025
18 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2022: $329 · 2023: $246 · 2024: $69.28 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $239.35 | 2023-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $195.75 | 2019-2022 | |
| Horizon Therapeutics Plc | $192.55 | 2022 | |
| Organogenesis INC. | $137.56 | 2023 | Puraply |
| Sebela Pharmaceuticals INC. | $88.19 | 2019 | |
| Smith+Nephew, INC. | $71.87 | 2019-2024 | Collagenase Santyl, Grafix Pl, Regranex |
| Abbott Laboratories | $66.87 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Stryker Corporation | $44.30 | 2019 | |
| Vaporox, INC. | $37.27 | 2025 | |
| Kerecis Limited | $28.07 | 2019 | |
| Mimedx Group, INC. | $25.64 | 2024 | |
| Integra Lifesciences Corporation | $20.87 | 2019 | |
| Grt US Holding, INC. | $18.58 | 2022 | |
| Allergan, INC. | $16.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $15.00 | 2019 | |
| Tactile Systems Technology INC | $12.05 | 2019 | |
| Bioventus LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.